DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: In general, the phenotypic spectrum observed in the dystrophinopathies is related to the specific tissue and degree of dystrophin expression, which, in large part, is determined by the “reading frame rule” [72].